Nachrichten zur CRISPR Therapeutics AG Aktie

Lange Zeit war es ruhig um die Aktie des Gen-Schere-Spezialisten CRISPR Therapeutics. In der vergangenen Woche hat sich das Papier…

Lange Zeit war es ruhig um die Aktie des Gen-Schere-Spezialisten CRISPR Therapeutics. In der vergangenen Woche hat sich das Papier…

Kulmbach (www.aktiencheck.de) - CRISPR Therapeutics-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie der CRISPR Therapeutics AG…

Mit einem vorbörslichen Kursplus von gut fünf Prozent kann die Aktie von CRISPR Therapeutics an die bisherige starke Wochenperformance anknüpfen.…

Mit einem vorbörslichen Kursplus von gut fünf Prozent kann die Aktie von CRISPR Therapeutics an die bisherige starke Wochenperformance anknüpfen.…

On Hump Day, investors piled into CRISPR Therapeutics (NASDAQ: CRSP) stock, sending its price more than 9% higher at the…

Seit mehr als sieben Jahren ist die US-Investorin Cathie Wood an dem Schweizer Pharmakonzern CRISPR Therapeutics beteiligt. Im vorangegangenen Quartal…

CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of 61.74% and 252.50%, respectively, for the quarter ended December 2024. Do…

CRISPR Therapeutics AG (CRSP) closed at $39.41 in the latest trading session, marking a -0.76% move from the prior day.…

Investing in stocks that arent performing well can be a good move, but only if there are good reasons to…

…

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $40.49, marking a +1.23% move from the previous day.…

Its the start of a new year, and that makes now the perfect time to load up on stocks that…

Some investors believe you make money when you buy a stock, not when you sell it. The logic behind this…

…

If youre an investor searching for the next big market winners, Wall Street analysts have zeroed in on one biotech…

Whats going on with CRISPR Therapeutics (NASDAQ: CRSP)? The companys shares have been southbound for the better part of three…

What do Apple (NASDAQ: AAPL) and Vertex Pharmaceuticals (NASDAQ: VRTX) have in common? At first glance, not much. The former…

Kulmbach (www.aktiencheck.de) - CRISPR Therapeutics-Aktienanalyse von "Der Aktionär": Jürgen Dreifürst vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie…

Investors looking for stocks that can make dramatic gains can find some in the biopharmaceutical industry. Right now, there are…

CRISPR Therapeutics (NASDAQ: CRSP) is recognized as a pioneer in the field of gene therapy. This biotechnology has the potential…

CRISPR Therapeutics stock hits 52-week low at $43.37…

Its getting harder these days to find great growth stocks trading for less than $100 a share. It almost seems…

On Nov. 21, shares of CRISPR Therapeutics (NASDAQ: CRSP) were down 47% from a peak they reached in March. This…

Godzilla and King Kong surely werent born big. They began small and grew over time to their gargantuan sizes even…

…

If you love investing in stocks youre bound to buy some losers. Long term CRISPR Therapeutics AG ( NASDAQ:CRSP...…

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of -8.76% and 93.84%, respectively, for the quarter ended June 2024. Do…

…

…

…

CRISPR Therapeutics to nominate Christian Rommel to board…